Title |
Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis
|
---|---|
Published in |
BMC Research Notes, August 2018
|
DOI | 10.1186/s13104-018-3670-5 |
Pubmed ID | |
Authors |
Fasil Wagnew, Setegn Eshetie, Getiye Dejenu Kibret, Abriham Zegeye, Getenet Dessie, Henok Mulugeta, Amanuel Alemu |
Abstract |
This meta-analysis was undertaken to estimate the prevalence of diabetic nephropathy and its association with hypertension in diabetics of sub-Saharan African countries. A total of 27 studies were included for the meta-analysis. The pooled overall prevalence of diabetic nephropathy was 35.3 (95% CI 27.46-43.14). In sub-group analyses by types of diabetes and regions, for instance, the prevalence was 41.4% (95% CI 32.2-50.58%) in type-2 diabetes mellitus and 29.7% (95% CI 14.3-45.1%) in Eastern Africa. Pooled point estimates from included studies revealed an increased risk of diabetic nephropathy with hypertension compared to without hypertension (OR = 1.67, 95% CI 1.31, 2.14). Diabetic nephropathy is a common complication in diabetic patients. Diabetic nephropathy complication is significantly higher in hypertensive patients. A preventive strategy should be adopted or planned to reduce diabetes mellitus and its complication of neuropathy, particularly in hypertensive. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 203 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 27 | 13% |
Student > Postgraduate | 17 | 8% |
Student > Ph. D. Student | 14 | 7% |
Student > Doctoral Student | 10 | 5% |
Researcher | 10 | 5% |
Other | 32 | 16% |
Unknown | 93 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 29% |
Nursing and Health Professions | 18 | 9% |
Biochemistry, Genetics and Molecular Biology | 14 | 7% |
Unspecified | 5 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 1% |
Other | 11 | 5% |
Unknown | 94 | 46% |